As upstream process development increasingly relies on high-throughput bioreactor platforms, the ability to generate dense, ...

Continuous processing can get products to market about 12 months faster than batch processing, according to a 2022 paper by the FDA. Understandably, the drive to transition to continuous bioprocessing ...

In recent years, fed-batch biomanufacturing has begun giving way to continuous manufacturing processes, as developers face pressure to balance affordability with high manufacturing quality. Although ...

Process intensification has reduced the cost of mAb manufacturing, but tweaks across bioproduction will be needed to reduce ...

Batch process scheduling and optimisation is a critical area of research that addresses the timing, sequencing, and allocation of production tasks in industries where manufacturing is carried out in ...